Esperion Therapeutics | ESPR - Eps Gewinn Pro Aktie

Aktienkurs
2.59
Täglich Wechseln
0.04 1.37%
Monatlich
-21.67%
Jährlich
48.56%
Q1 Prognose
2.47

Fiscal Kalender Aktuell Konsens Zuletzt Datum




Eps Veränderung Datum
AbbVie USD 2.71 0.85 2025-12
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Alterity Therapeutics Limited AUD 0 0 2023-12
Amarin USD 0.14 0.06 2025-12
Amgen USD 5.29 0.35 2025-12
Biogen USD 1.99 2.82 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Cipla INR 15.2 1.52 2025-12
CSL USD 5.07 3 2025-12
Cytokinetics USD -1.5 1.05 2025-12
Daiichi Sankyo JPY 46.79 22.27 2025-12
Eli Lilly USD 7.54 0.52 2025-12
Esperion Therapeutics USD 0.26 0.42 2025-12
Geron USD -0.05 0.02 2025-12
Grifols EUR 0.29 0.11 2026-03
Halozyme Therapeutics USD -0.24 1.96 2025-12
Heron Therapeutics USD -0.02 0.02 2025-12
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
Merck USD 2.04 0.54 2025-12
Minerva Neurosciences USD -0.56 3.53 2024-12
Moderna USD -2.11 1.6 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Pfizer USD 0.66 0.21 2025-12
PTC Therapeutics USD -1.67 1.87 2025-12
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 11.44 0.39 2025-12
Sanofi EUR 1.53 1.38 2025-12
Sarepta Therapeutics USD -3.58 3.45 2025-12
United Therapeutics USD 7.7 0.54 2025-12
Vanda Pharmaceuticals USD -0.09 0 2024-12